Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India
Shilpa CDMO has announced a $50m investment to boost its peptide manufacturing capabilities, citing growing global demand for GLP-1s and new generations of complex peptide…
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 4 06:46 ETSource: Manufacturing Chemist
From the source
Read at manufacturingchemist.comShilpa CDMO invests $50m to expand peptide manufacturing capacity in India
Shilpa CDMO has announced a $50m investment to boost its peptide manufacturing capabilities, citing growing global demand for GLP-1s and new generations of complex peptide therapeutics.
